Levodopa motor complications in Parkinson's disease

José A. Obeso, C. Warren Olanow, John Nutt

Research output: Contribution to journalArticle

341 Citations (Scopus)

Abstract

Parkinson's disease (PD) is an age-related neurodegenerative disorder with an average onset age of 60 years. In the United States, approximately one million persons suffer from PD, and there are 60 000 newly diagnosed cases every year. The estimated cost of PD to society is $27 billion per year. Based on United States Census Bureau projections, it is estimated that the frequency of PD will increase fourfold by the year 2040, making it an even larger burden on patients, their families and society.

Original languageEnglish (US)
JournalTrends in Neurosciences
Volume23
Issue number10 SUPPL.
StatePublished - 2000

Fingerprint

Levodopa
Parkinson Disease
Cost of Illness
Censuses
Age of Onset
Neurodegenerative Diseases

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Levodopa motor complications in Parkinson's disease. / Obeso, José A.; Olanow, C. Warren; Nutt, John.

In: Trends in Neurosciences, Vol. 23, No. 10 SUPPL., 2000.

Research output: Contribution to journalArticle

Obeso, JA, Olanow, CW & Nutt, J 2000, 'Levodopa motor complications in Parkinson's disease', Trends in Neurosciences, vol. 23, no. 10 SUPPL..
Obeso, José A. ; Olanow, C. Warren ; Nutt, John. / Levodopa motor complications in Parkinson's disease. In: Trends in Neurosciences. 2000 ; Vol. 23, No. 10 SUPPL.
@article{b043ea824467411ca512d4fabd45fc45,
title = "Levodopa motor complications in Parkinson's disease",
abstract = "Parkinson's disease (PD) is an age-related neurodegenerative disorder with an average onset age of 60 years. In the United States, approximately one million persons suffer from PD, and there are 60 000 newly diagnosed cases every year. The estimated cost of PD to society is $27 billion per year. Based on United States Census Bureau projections, it is estimated that the frequency of PD will increase fourfold by the year 2040, making it an even larger burden on patients, their families and society.",
author = "Obeso, {Jos{\'e} A.} and Olanow, {C. Warren} and John Nutt",
year = "2000",
language = "English (US)",
volume = "23",
journal = "Trends in Neurosciences",
issn = "0378-5912",
publisher = "Elsevier Limited",
number = "10 SUPPL.",

}

TY - JOUR

T1 - Levodopa motor complications in Parkinson's disease

AU - Obeso, José A.

AU - Olanow, C. Warren

AU - Nutt, John

PY - 2000

Y1 - 2000

N2 - Parkinson's disease (PD) is an age-related neurodegenerative disorder with an average onset age of 60 years. In the United States, approximately one million persons suffer from PD, and there are 60 000 newly diagnosed cases every year. The estimated cost of PD to society is $27 billion per year. Based on United States Census Bureau projections, it is estimated that the frequency of PD will increase fourfold by the year 2040, making it an even larger burden on patients, their families and society.

AB - Parkinson's disease (PD) is an age-related neurodegenerative disorder with an average onset age of 60 years. In the United States, approximately one million persons suffer from PD, and there are 60 000 newly diagnosed cases every year. The estimated cost of PD to society is $27 billion per year. Based on United States Census Bureau projections, it is estimated that the frequency of PD will increase fourfold by the year 2040, making it an even larger burden on patients, their families and society.

UR - http://www.scopus.com/inward/record.url?scp=0033695441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033695441&partnerID=8YFLogxK

M3 - Article

C2 - 11052214

AN - SCOPUS:0033695441

VL - 23

JO - Trends in Neurosciences

JF - Trends in Neurosciences

SN - 0378-5912

IS - 10 SUPPL.

ER -